Danaher company profile

DHR · NYSE · USD

$233.02Change from previous close: +0.37%Absolute change: +$0.86

Close · November 13, 2026

Company profile

Danaher has 58,000 employees and is headquartered in Washington, United States.

Hospitals, physicians' offices, reference laboratories and other critical care settings are among the customers for the company's clinical instruments, consumables, software and services, which are used to diagnose disease and support treatment decisions. Companies developing and manufacturing therapeutics buy its cell culture media, filtration technologies, chromatography resins, single-use hardware and manufacturing suite design services. Life sciences laboratories use its mass spectrometers, microscopes, flow cytometry and genomics systems, along with antibodies and reagents sold under brands such as ABCAM, BECKMAN COULTER, LEICA MICROSYSTEMS, SCIEX and PALL. Sales are made in the United States, China and other markets abroad.

In the fiscal year ended December 2025, revenue was 24.6 billion USD, up 2.9% from the previous year, and net income was 3.6 billion USD. By region, North America accounted for 42.2% of revenue, High Growth Markets for 28.6%, Western Europe for 24.2% and other developed markets for 5.1%. The company had 58,000 employees and is headquartered in Washington, District of Columbia. It was incorporated in 1969.

Company facts

Industry
Diagnostics & Research
Headquarters
2200 Pennsylvania Avenue N.W., 20037-1701, Washington
Employees
58,000
Chief executive
Julie Montgomery
Founded
1969
Fiscal year
January - December
Listing
DHR · NYSE
Indices
S&P 500
Currency
USD
ISIN
US2358511028

Danaher and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
DanaherDHRUnited States$163.94B58,00022.0%38.6
Thermo Fisher ScientificTMOUnited States$259.44B125,00019.1%36.9
WatersWATUnited States$90.45B15,00016.0%192.6
IDEXX LaboratoriesIDXXUnited States$55.48B11,00032.5%47.0
Agilent TechnologiesAUnited States$49.04B18,20024.5%34.3
NateraNTRAUnited States$46.27B6,135-8.5%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Danaher with its competitors